uniQure
QURE
#5316
Rank
NZ$2.45 B
Marketcap
NZ$39.43
Share price
-10.75%
Change (1 day)
267.20%
Change (1 year)

Revenue for uniQure (QURE)

Revenue in 2025 (TTM): NZ$27.04 Million

According to uniQure's latest financial reports the company's current revenue (TTM ) is NZ$27.31 Million. In 2024 the company made a revenue of NZ$48.08 Million an increase over the revenue in the year 2023 that were of NZ$25.05 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for uniQure from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$27.04 M-43.76%
2024 NZ$48.08 M91.94%
2023 NZ$25.05 M-85.06%
2022 NZ$0.16 B-78.14%
2021 NZ$0.76 B1375.55%
2020 NZ$51.99 M380.91%
2019 NZ$10.81 M-35.73%
2018 NZ$16.82 M-8.85%
2017 NZ$18.45 M-48.89%
2016 NZ$36.1 M141.06%
2015 NZ$14.97 M98.21%
2014 NZ$7.55 M54.2%
2013 NZ$4.9 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
NZ$62.37 B 228,272.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$57 M 108.72%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
NZ$0.18 B 559.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
NZ$36.18 M 32.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$82.41 B 301,627.39%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
NZ$5.36 B 19,543.20%๐Ÿ‡บ๐Ÿ‡ธ USA